Cancer-causing karyotypes: chromosomal equilibria between destabilizing aneuploidy and stabilizing selection for oncogenic function

Cancer Genetics and Cytogenetics

Volumn 188, Issue 1, 2009, Pages 1-25

  Li, Lin ^a   McCormack, Amanda A ^a   Nicholson, Joshua M ^a   Fabarius, Alice ^b   Hehlmann, Ruediger ^b   Sachs, Rainer K ^a   Duesberg, Peter H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANEUPLOIDY; ARTICLE; CELL TRANSFORMATION; CHROMOSOME; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; KARYOTYPE; MOLECULAR CLONING; MUTATION; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL;

ANEUPLOIDY; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOMAL INSTABILITY; CHROMOSOME PAINTING; CHROMOSOMES, HUMAN; CLONE CELLS; EPITHELIAL CELLS; GENE DOSAGE; GENE FREQUENCY; GENETIC MARKERS; HUMANS; KARYOTYPING; NEOPLASMS; SIMIAN VIRUS 40; TUMOR MARKERS, BIOLOGICAL;

EID: 56849133855     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2008.08.016     Document Type: Article

References (126)

1. Levan A., and Biesele J.J. Role of chromosomes in cancerogenesis, as studied in serial tissue culture of mammalian cells. Ann N Y Acad Sci 71 (1958) 1022-1053
2. Koller P.C. The role of chromosomes in cancer biology (1972), Springer-Verlag, New York
3. Wolman S.R. Cytogenetic heterogeneity: its role in tumor evolution. Cancer Genet Cytogenet 19 (1986) 129-140
4. Albertson D.G., Collins C., McCormick F., and Gray J.W. Chromosome aberrations in solid tumors. Nat Genet 34 (2003) 369-376
5. Gollin S.M. Mechanisms leading to chromosomal instability. Semin Cancer Biol 15 (2005) 33-42
6. Lengauer C., Kinzler K.W., and Vogelstein B. Genetic instability in colorectal cancers. Nature 386 (1997) 623-627
7. Duesberg P., Rausch C., Rasnick D., and Hehlmann R. Genetic instability of cancer cells is proportional to their degree of aneuploidy. Proc Natl Acad Sci U S A 95 (1998) 13692-13697
8. Fabarius A., Hehlmann R., and Duesberg P.H. Instability of chromosome structure in cancer cells increases exponentially with degrees of aneuploidy. Cancer Genet Cytogenet 143 (2003) 59-72
9. Duesberg P., Fabarius A., and Hehlmann R. Aneuploidy, the primary cause of the multilateral genomic instability of neoplastic and preneoplastic cells. IUBMB Life 56 (2004) 65-81
10. Li R., Hehlmann R., Sachs R., and Duesberg P. Chromosomal alterations cause the high rates and wide ranges of drug resistance in cancer cells. Cancer Genet Cytogenet 163 (2005) 44-56
11. Duesberg P., Li R., Fabarius A., and Hehlmann R. Aneuploidy and cancer: from correlation to causation. Contrib Microbiol 13 (2006) 16-44
12. Winge O. Zytologische Untersuchungen über die Natur maligner Tumoren: II. Teerkarzinome bei Mäusen [Cytological studies on the nature of malignant tumors: II. Tar carcinomas in mice. In German]. Z Zellforsch Mikrosk Anat 10 (1930) 683-735
13. Nowell P.C. The clonal evolution of tumor cell populations. Science 194 (1976) 23-28
14. Wilkens L., Flemming P., Gebel M., Bleck J., Terkamp C., Wingen L., Kreipe H., and Schlegelberger B. Induction of aneuploidy by increasing chromosomal instability during dedifferentiation of hepatocellular carcinoma. Proc Natl Acad Sci U S A 101 (2004) 1309-1314
15. Fabarius A., Li R., Yerganian G., Hehlmann R., and Duesberg P. Specific clones of spontaneously evolving karyotypes generate individuality of cancers. Cancer Genet Cytogenet 180 (2008) 89-99
16. Reshmi S.C., Saunders W.S., Kudla D.M., Ragin C.R., and Gollin S.M. Chromosomal instability and marker chromosome evolution in oral squamous cell carcinoma. Genes Chromosomes Cancer 41 (2004) 38-46
17. Gusev Y., Kagansky V., and Dooley W.C. Long-term dynamics of chromosomal instability in cancer: a transition probability model. Math Comput Model 33 (2001) 1253-1273
18. Duesberg P., Li R., Fabarius A., and Hehlmann R. The chromosomal basis of cancer. Cell Oncol 27 (2005) 293-318
19. Foulds L. Neoplastic development (1969), Academic Press, London, New York, San Francisco Vol. 1
20. Wolman S.R. Karyotypic progression in human tumors. Cancer Metastasis Rev 2 (1983) 257-293
21. Balaban G.B., Herlyn M., Clark Jr. W.H., and Nowell P.C. Karyotypic evolution in human malignant melanoma. Cancer Genet Cytogenet 19 (1986) 113-122
22. Reeves B.R., Nash R., Lawler S.D., Fisher C., Treleaven J.G., and Wiltshaw E. Serial cytogenetic studies showing persistence of original clone in Hodgkin's disease. Cancer Genet Cytogenet 50 (1990) 1-8
23. Tsao J.L., Yatabe Y., Markl I.D., Hajyan K., Jones P.A., and Shibata D. Bladder cancer genotype stability during clinical progression. Genes Chromosomes Cancer 29 (2000) 26-32
24. Wang E., Voiculescu S., Le Poole I.C., El-Gamil M., Li X., Sabatino M., Robbins P.F., Nickoloff B.J., and Marincola F.M. Clonal persistence and evolution during a decade of recurrent melanoma. J Invest Dermatol 126 (2006) 1372-1377
25. Loeper S., Romeike B.F., Heckmann N., Jung V., Henn W., Feiden W., Zang K.D., and Urbschat S. Frequent mitotic errors in tumor cells of genetically micro-heterogeneous glioblastomas. Cytogenet Cell Genet 94 (2001) 1-8
26. Mitelman F, Johansson B, Mertens F, editors. Mitelman database of chromosome aberrations in cancer [Internet]. Updated quarterly. Available at http://cgap.nci.nih.gov/Chromosomes/Mitelman. Accessed June 2008.
27. Kallioniemi O.P., Kallioniemi A., Piper J., Isola J., Waldman F.M., Gray J.W., and Pinkel D. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer 10 (1994) 231-243
28. Gebhart E., and Liehr T. Patterns of genomic imbalances in human solid tumors (Review). Int J Oncol 16 (2000) 383-399
29. Baudis M. Genomic imbalances in 5918 malignant epithelial tumors: an explorative meta-analysis of chromosomal CGH data. BMC Cancer 7 (2007) 226
30. Mitelman F., Mertens F., and Johansson B. A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat Genet (1997) 15 Spec No:S417-S474
31. Jin Y., Jin C., Lv M., Tsao S.W., Zhu J., Wennerberg J., Mertens F., and Kwong Y.L. Karyotypic evolution and tumor progression in head and neck squamous cell carcinomas. Cancer Genet Cytogenet 156 (2005) 1-7
32. Kuukasjärvi T., Karhu R., Tanner M., Kähkönen M., Schäffer A., Nupponen N., Pennanen S., Kallioniemi A., Kallioniemi O.P., and Isola J. Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. Cancer Res 57 (1997) 1597-1604
33. Nupponen N.N., Hyytinen E.R., Kallioniemi A.H., and Visakorpi T. Genetic alterations in prostate cancer cell lines detected by comparative genomic hybridization. Cancer Genet Cytogenet 101 (1998) 53-57
34. Richter J., Beffa L., Wagner U., Schraml P., Gasser T.C., Moch H., Mihatsch M.J., and Sauter G. Patterns of chromosomal imbalances in advanced urinary bladder cancer detected by comparative genomic hybridization. Am J Pathol 153 (1998) 1615-1621
35. Weber R.G., Scheer M., Born I.A., Joos S., Cobbers J.M., Hofele C., Reifenberger G., Zöller J.E., and Lichter P. Recurrent chromosomal imbalances detected in biopsy material from oral premalignant and malignant lesions by combined tissue microdissection, universal DNA amplification, and comparative genomic hybridization. Am J Pathol 153 (1998) 295-303
36. Walch A., Bink K., Gais P., Stangl S., Hutzler P., Aubele M., Mueller J., Höfler H., and Werner M. Evaluation of c-erbB-2 overexpression and Her-2/neu gene copy number heterogeneity in Barrett's adenocarcinoma. Anal Cell Pathol 20 (2000) 25-32
37. Al-Mefty O., Kadri P.A., Pravdenkova S., Sawyer J.R., Stangeby C., and Husain M. Malignant progression in meningioma: documentation of a series and analysis of cytogenetic findings. J Neurosurg 101 (2004) 210-218
38. Ma X.J., Salunga R., Tuggle J.T., Gaudet J., Enright E., McQuary P., Payette T., Pistone M., Stecker K., Zhang B.M., Zhou Y.X., Varnholt H., Smith B., Gadd M., Chatfield E., Kessler J., Baer T.M., Erlander M.G., and Sgroi D.C. Gene expression profiles of human breast cancer progression. Proc Natl Acad Sci U S A 100 (2003) 5974-5979
39. Crnalic S., Panagopoulos I., Boquist L., Mandahl N., Stenling R., and Löfvenberg R. Establishment and characterisation of a human clear cell sarcoma model in nude mice. Int J Cancer 101 (2002) 505-511
40. Nichols W.W. Relationships of viruses, chromosomes and carcinogenesis. Hereditas 50 (1963) 51-80
41. Wolman S.R., Cohen T.I., and Becker F.F. Chromosome analysis of hepatocellular carcinoma 7777 and correlation with α-fetoprotein production. Cancer Res 37 (1977) 2624-2627
42. Murray M., James Z.H., and Martin W.B. A study of the cytology and karyotype of the canine transmissible venereal tumour. Res Vet Sci 10 (1969) 565-568
43. Levan A. Chromosome abnormalities and carcinogenesis. In: Lima-de-Faria A. (Ed). Handbook of molecular cytology (1969), American Elsevier Publishing, New York 716-731
44. Pearse A.M., and Swift K. Allograft theory: transmission of devil facial-tumour disease. Nature 439 (2006) 549
45. Eshleman J.R., Casey G., Kochera M.E., Sedwick W.D., Swinler S.E., Veigl M.L., Willson J.K., Schwartz S., and Markowitz S.D. Chromosome number and structure both are markedly stable in RER colorectal cancers and are not destabilized by mutation of p53. Oncogene 17 (1998) 719-725
46. Roschke A.V., Stover K., Tonon G., Schäffer A.A., and Kirsch I.R. Stable karyotypes in epithelial cancer cell lines despite high rates of ongoing structural and numerical chromosomal instability. Neoplasia 4 (2002) 19-31
47. Macville M., Schröck E., Padilla-Nash H., Keck C., Ghadimi B.M., Zimonjic D., Popescu N., and Ried T. Comprehensive and definitive molecular cytogenetic characterization of HeLa cells by spectral karyotyping. Cancer Res 59 (1999) 141-150
48. Grigorova M., Staines J.M., Ozdag H., Caldas C., and Edwards P.A. Possible causes of chromosome instability: comparison of chromosomal abnormalities in cancer cell lines with mutations in BRCA1, BRCA2, CHK2 and BUB1. Cytogenet Genome Res 104 (2004) 333-340
49. Camps J., Ponsa I., Ribas M., Prat E., Egozcue J., Peinado M.A., and Miro R. Comprehensive measurement of chromosomal instability in cancer cells: combination of fluorescence in situ hybridization and cytokinesis-block micronucleus assay. FASEB J 19 (2005) 828-830
50. Gorringe K.L., Chin S.F., Pharoah P., Staines J.M., Oliveira C., Edwards P.A., and Caldas C. Evidence that both genetic instability and selection contribute to the accumulation of chromosome alterations in cancer. Carcinogenesis 26 (2005) 923-930
51. Heng H.H., Stevens J.B., Liu G., Bremer S.W., Ye K.J., Reddy P.V., Wu G.S., Wang Y.A., Tainsky M.A., and Ye C.J. Stochastic cancer progression driven by non-clonal chromosome aberrations. J Cell Physiol 208 (2006) 461-472
52. Kraemer P.M., Petersen D.F., and Van Dilla M.A. DNA constancy in heteroploidy and the stem line theory of tumors. Science 174 (1971) 714-717
53. American Type Culture Collection. Catalogue of cell lines and hybridomas (1985-1992), The Collection, Rockville, MD
54. Nelson-Rees W.A., Hunter L., Darlington G.J., and O'Brien S.J. Characteristics of HeLa strains: permanent vs. variable features. Cytogenet Cell Genet 27 (1980) 216-231
55. King M. Species evolution: the role of chromosome change (1993), Cambridge University Press, Cambridge
56. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 37 (1965) 614-636
57. Harris H. The cells of the body: a history of somatic cell genetics (1995), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
58. Duesberg P., and Rasnick D. Aneuploidy, the somatic mutation that makes cancer a species of its own. Cell Motil Cytoskeleton 47 (2000) 81-107
59. Saxon P.J., Srivatsan E.S., and Stanbridge E.J. Introduction of human chromosome 11 via microcell transfer controls tumorigenic expression of HeLa cells. EMBO J 5 (1986) 3461-3466
60. Theile M., Hartmann S., Scherthan H., Arnold W., Deppert W., Frege R., Glaab F., Haensch W., and Scherneck S. Suppression of tumorigenicity of breast cancer cells by transfer of human chromosome 17 does not require transferred BRCA1 and p53 genes. Oncogene 10 (1995) 439-447
61. Seitz S., Frege R., Jacobsen A., Weimer J., Arnold W., von Haefen C., Niederacher D., Schmutzler R., Arnold N., and Scherneck S. A network of clinically and functionally relevant genes is involved in the reversion of the tumorigenic phenotype of MDA-MB-231 breast cancer cells after transfer of human chromosome 8. Oncogene 24 (2005) 869-879
62. Ko J.M., Yau W.L., Chan P.L., Lung H.L., Yang L., Lo P.H., Tang J.C., Srivastava G., Stanbridge E.J., and Lung M.L. Functional evidence of decreased tumorigenicity associated with monochromosome transfer of chromosome 14 in esophageal cancer and the mapping of tumor-suppressive regions to 14q32. Genes Chromosomes Cancer 43 (2005) 284-293
63. Steck P.A., Ligon A.H., Cheong P., Yung W.K., and Pershouse M.A. Two tumor suppressive loci on chromosome 10 involved in human glioblastomas. Genes Chromosomes Cancer 12 (1995) 255-261
64. Stewart N., and Bacchetti S. Expression of SV40 large T antigen, but not small t antigen, is required for the induction of chromosomal aberrations in transformed human cells. Virology 180 (1991) 49-57
65. Bocchetta M., Di Resta I., Powers A., Fresco R., Tosolini A., Testa J.R., Pass H.I., Rizzo P., and Carbone M. Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity. Proc Natl Acad Sci U S A 97 (2000) 10214-10219
66. Kendall S.D., Linardic C.M., Adam S.J., and Counter C.M. A network of genetic events sufficient to convert normal human cells to a tumorigenic state. Cancer Res 65 (2005) 9824-9828
67. Ewald D., Li M., Efrat S., Auer G., Wall R.J., Furth P.A., and Hennighausen L. Time-sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen. Science 273 (1996) 1384-1386
68. Süss R., Kinzel V., and Scribner J.D. Cancer: experiments and concepts (1973), Springer-Verlag, New York
69. Duesberg P.H. Are cancers dependent on oncogenes or on aneuploidy?. Cancer Genet Cytogenet 143 (2003) 89-91
70. Ahuja D., Sáenz-Robles M.T., and Pipas J.M. SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation. Oncogene 24 (2005) 7729-7745
71. Yerganian G., Shein H.M., and Enders J.F. Chromosomal disturbances observed in human fetal renal cells transformed in vitro by simian virus 40 and carried in culture. Cytogenetics 1 (1962) 314-324
72. Moorhead P.S., and Saksela E. The sequence of chromosome aberrations during SV 40 transformation of a human diploid cell strain. Hereditas 52 (1965) 271-284
73. Wolman S.R., Steinberg M.L., and Defendi V. Simian virus 40-induced chromosome changes in human epidermal cultures. Cancer Genet Cytogenet 2 (1980) 39-46
74. Ray F.A., Peabody D.S., Cooper J.L., Cram L.S., and Kraemer P.M. SV40 T antigen alone drives karyotype instability that precedes neoplastic transformation of human diploid fibroblasts. J Cell Biochem 42 (1990) 13-31
75. Li R., Sonik A., Stindl R., Rasnick D., and Duesberg P. Aneuploidy vs. gene mutation hypothesis of cancer: recent study claims mutation, but is found to support aneuploidy. Proc Natl Acad Sci U S A 97 (2000) 3236-3241
76. Sotillo R., Hernando E., Díaz-Rodríguez E., Teruya-Feldstein J., Cordón-Cardo C., Lowe S.W., and Benezra R. Mad2 overexpression promotes aneuploidy and tumorigenesis in mice. Cancer Cell 11 (2007) 9-23
77. Macpherson I., and Montagnier L. Agar suspension culture for the selective assay of cells transformed by polyoma virus. Virology 23 (1964) 291-294
78. Weaver B.A., and Cleveland D.W. Does aneuploidy cause cancer? [Erratum in: Curr Opin Cell Biol 2007;19:246]. Curr Opin Cell Biol 18 (2006) 658-667
79. Deng W., Tsao S.W., Lucas J.N., Leung C.S., and Cheung A.L. A new method for improving metaphase chromosome spreading. Cytometry A 51 (2003) 46-51
80. Heim S., and Mitelman F. Cancer cytogenetics: chromosomal and molecular genetic aberrations of tumor cells. 2nd ed. (1995), Wiley-Liss, New York
81. Richter J., Jiang F., Görög J.P., Sartorius G., Egenter C., Gasser T.C., Moch H., Mihatsch M.J., and Sauter G. Marked genetic differences between stage pTa and stage pT1 papillary bladder cancer detected by comparative genomic hybridization. Cancer Res 57 (1997) 2860-2864
82. O'Brien S.J., Menotti-Raymond M., Murphy W.J., Nash W.G., Wienberg J., Stanyon R., Copeland N.G., Jenkins N.A., Womack J.E., and Marshall Graves J.A. The promise of comparative genomics in mammals. Science 286 (1999) 458-462 479-81
83. Mitelman F., Johansson B., Mandahl N., and Mertens F. Clinical significance of cytogenetic findings in solid tumors. Cancer Genet Cytogenet 95 (1997) 1-8
84. Doak S.H. Aneuploidy in upper gastro-intestinal tract cancers: a potential prognostic marker?. Mutat Res 651 (2008) 93-104
85. Duesberg P., Li R., Sachs R., Fabarius A., Upender M.B., and Hehlmann R. Cancer drug resistance: the central role of the karyotype. Drug Resist Updat 10 (2007) 51-58
86. Pollack J.R., Sørlie T., Perou C.M., Rees C.A., Jeffrey S.S., Lonning P.E., Tibshirani R., Botstein D., Børresen-Dale A.L., and Brown P.O. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc Natl Acad Sci U S A 99 (2002) 12963-12968
87. Aggarwal A., Leong S.H., Lee C., Kon O.L., and Tan P. Wavelet transformations of tumor expression profiles reveals a pervasive genome-wide imprinting of aneuploidy on the cancer transcriptome. Cancer Res 65 (2005) 186-194
88. Tsafrir D., Bacolod M., Selvanayagam Z., Tsafrir I., Shia J., Zeng Z., Liu H., Krier C., Stengel R.F., Barany F., Gerald W.L., Paty P.B., Domany E., and Notterman D.A. Relationship of gene expression and chromosomal abnormalities in colorectal cancer. Cancer Res 66 (2006) 2129-2137
89. Gao C., Furge K., Koeman J., Dykema K., Su Y., Cutler M.L., Werts A., Haak P., and Vande Woude G.F. Chromosome instability, chromosome transcriptome, and clonal evolution of tumor cell populations. Proc Natl Acad Sci U S A 104 (2007) 8995-9000
90. Duesberg P., Li R., Rasnick D., Rausch C., Willer A., Kraemer A., Yerganian G., and Hehlmann R. Aneuploidy precedes and segregates with chemical carcinogenesis. Cancer Genet Cytogenet 119 (2000) 83-93
91. Heng H.H., Bremer S.W., Stevens J., Ye K.J., Miller F., Liu G., and Ye C.J. Cancer progression by non-clonal chromosome aberrations. J Cell Biochem 98 (2006) 1424-1435
92. Duesberg P. Chromosomal chaos and cancer. Sci Am 296 5 (2007) 52-59
93. Oshimura M., and Barrett J.C. Chemically induced aneuploidy in mammalian cells: mechanisms and biological significance in cancer. Environ Mutagen 8 (1986) 129-159
94. Duesberg P. Does aneuploidy or mutation start cancer?. Science 307 (2005) 41-42
95. Saggioro D., Szpirer J., and Szpirer C. The effect of ploidy and colcemid on the frequency of spontaneous transformation of cultured cells. Cell Biol Int Rep 6 (1982) 29-38
96. Rajagopalan H., and Lengauer C. Aneuploidy and cancer. Nature 432 (2004) 338-341
97. Knoerr-Gaertner H., Schuhmann R., Kraus H., and Uebele-Kallhardt B. Comparative cytogenetic and histologic studies on early malignant transformation in mesothelial tumors of the ovary. Hum Genet 35 (1977) 281-297
98. Bocking A., and Chatelain R. Diagnostic and prognostic value of DNA cytometry in gynecologic cytology. Anal Quant Cytol Histol 11 (1989) 177-186
99. Marquardt H., and Glass E. Die Veränderungen der Häufigkeit euploider and aneuploider Chromosomenzahlen in der hepatektomierten Rattenleber bei Buttergelb-Verfütterung. Naturwissenschaften 44 (1957) 640 [In German]
100. Marquardt H., and Gläss E. Alterations of the frequencies of euploid and aneuploid chromosome numbers in the hepatectomized rat liver after feeding butter yellow. Naturwissenschaften 44 (1957) 640 [In German]
101. Duesberg P., and Li R. Multistep carcinogenesis: a chain reaction of aneuploidizations. Cell Cycle 2 (2003) 202-210
102. Cairns J. Cancer, science and society (1978), Freeman, San Francisco: W.H
103. Pitot H.C. Fundamentals of oncology. 4th ed. (2002), Marcel Dekker, New York rev. and expanded
104. Weaver B.A., Silk A.D., Montagna C., Verdier-Pinard P., and Cleveland D.W. Aneuploidy acts both oncogenically and as a tumor suppressor. Cancer Cell 11 (2007) 25-36
105. Torres E.M., Williams B.R., and Amon A. Aneuploidy: cells losing their balance. Genetics 179 (2008) 737-746
106. Hernandez D., and Fisher E.M. Mouse autosomal trisomy: two's company, three's a crowd. Trends Genet 15 (1999) 241-247
107. Hassold T.J. Chromosome abnormalities in human reproductive wastage. Trends Genet 2 (1986) 105-110
108. Saksela E., and Moorhead P.S. Aneuploidy in the degenerative phase of serial cultivation of human cell strains. Proc Natl Acad Sci U S A 50 (1963) 390-395
109. Tooze J. The molecular biology of tumour viruses. 1st ed (1973), Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
110. Marx J. Debate surges over the origins of genomic defects in cancer. Science 297 (2002) 544-546
111. Gibbs W.W. Untangling the roots of cancer. Sci Am 289 1 (2003) 56-65
112. Schneider B.L., and Kulesz-Martin M. Destructive cycles: the role of genomic instability and adaptation in carcinogenesis. Carcinogenesis 25 (2004) 2033-2044
113. Harris H. A long view of fashions in cancer research. Bioessays 27 (2005) 833-838
114. Radford I.R. Chromosomal rearrangement as the basis for human tumourigenesis. Int J Radiat Biol 80 (2004) 543-557
115. Hahn W.C., Counter C.M., Lundberg A.S., Beijersbergen R.L., Brooks M.W., and Weinberg R.A. Creation of human tumour cells with defined genetic elements. Nature 400 (1999) 464-468
116. Lodish H., Berk A., Matsudaira P., Kaiser C.A., Krieger M., Scott M.P., Zipursky S.L., and Darnell J. Molecular cell biology. 5th ed (2004), Freeman, New York: W.H
117. Lewin B, Cassimeris L, Lingappa VR, Plopper B. Cells. Chapter 13. Sudbury, MA: Jones & Bartlett, 2007.
118. Hartwell L.H., Hood L., Goldberg M.L., Reynolds A.E., Silver L.M., and Veres R.C. Genetics: from genes to genomes. 3rd ed. (2008), McGraw-Hill, New York p. 698
119. Lengauer C., and Wang Z. From spindle checkpoint to cancer. Nat Genet 36 (2004) 1144-1145
120. Li R., Rasnick D., and Duesberg P. Correspondence re: D. Zimonjic et al. Derivation of human tumor cells in vitro without widespread genomic instability [Comment on Cancer Res 61 (2001) 8838-8844 [Erratum in: Cancer Res 2002;62:7380]. Cancer Res 2002;62:6345-8; author reply 6348-9
121. Akagi T., Sasai K., and Hanafusa H. Refractory nature of normal human diploid fibroblasts with respect to oncogene-mediated transformation. Proc Natl Acad Sci U S A 100 (2003) 13567-13572
122. Mahale A.M., Khan Z.A., Igarashi M., Nanjangud G.J., Qiao R.F., Yao S., Lee S.W., and Aaronson S.A. Clonal selection in malignant transformation of human fibroblasts transduced with defined cellular oncogenes. Cancer Res 68 (2008) 1417-1426
123. Teixeira M.R., and Heim S. Multiple numerical chromosome aberrations in cancer: what are their causes and what are their consequences?. Semin Cancer Biol 15 (2005) 3-12
124. Mitelman F. Recurrent chromosome aberrations in cancer. Mutat Res 462 (2000) 247-253
125. Sjöblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D., Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K., Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W., and Velculescu V.E. The consensus coding sequences of human breast and colorectal cancers. Science 314 (2006) 268-274
126. Wood L.D., Parsons D.W., Jones S., Lin J., Sjöblom T., Leary R.J., Shen D., Boca S.M., Barber T., Ptak J., Silliman N., Szabo S., Dezso Z., Ustyanksky V., Nikolskaya T., Nikolsky Y., Karchin R., Wilson P.A., Kaminker J.S., Zhang Z., Croshaw R., Willis J., Dawson D., Shipitsin M., Willson J.K., Sukumar S., Polyak K., Park B.H., Pethiyagoda C.L., Pant P.V., Ballinger D.G., Sparks A.B., Hartigan J., Smith D.R., Suh E., Papadopoulos N., Buckhaults P., Markowitz S.D., Parmigiani G., Kinzler K.W., Velculescu V.E., and Vogelstein B. The genomic landscapes of human breast and colorectal cancers. Science 318 (2007) 1108-1113